Search results for "Hepatitis C"
Did you mean "hepatitis"?
Sort by: Relevance | Newest | OldestScreening for latent TB may miss higher-risk patients
A study of one large U.S. health system found that risk factors for latent tuberculosis (TB) were not associated with greater likelihood of screening.
https://immattersacp.org/weekly/archives/2024/01/23/4.htm
23 Jan 2024
Hepatitis C drugs offer new options
The approval of multiple drugs in 2013 and 2014 that are able to cure hepatitis C without the use of interferon has dramatically changed the screening, treatment, and epidemiologic paradigms of the virus. Soon, internists will be involved in this rapidly changing area of health care.
https://immattersacp.org/archives/2015/01/hepatitis.htm
1 Jan 2015
USPSTF expands hepatitis C screening recommendation to most adults
All adults ages 18 to 79 years should now be screened at least once, but people who use injection drugs and pregnant women may require screening more often.
https://immattersacp.org/weekly/archives/2020/03/10/2.htm
10 Mar 2020
Recall of glucose test strips; approval for hepatitis C drug
This update covers a class I recall of blood glucose test strips which might cause clinicians to overlook hypoglycemia.
https://immattersacp.org/archives/2016/04/fda.htm
1 Apr 2016
About one-third of Americans with HCV had evidence of viral clearance in past decade
The highest proportion of hepatitis C virus (HCV) cure or clearance among all age groups and payers was 49% among commercially insured patients ages 60 years and older, a study found.
https://immattersacp.org/weekly/archives/2023/07/11/4.htm
11 Jul 2023
Hepatitis C diagnosis, treatment changing rapidly
This issue covers topics including management of hepatitis and the effect of new direct-pay practice models on primary care practice.
https://immattersacp.org/archives/2015/01/editors.htm
1 Jan 2015
ACP and the American Academy of HIV Medicine collaborate on new guide to hepatitis C testing
The new guide includes a summary of the latest testing recommendations; diagnostic, billing, and laboratory codes for testing; resources for referrals to HCV-experienced clinicians; and information on patient interactions, education, conversations, and case examples.
https://immattersacp.org/weekly/archives/2017/05/16/5.htm
16 May 2017
New hepatitis C treatments cost-effective, may exceed insurers' willingness to pay
New therapies for hepatitis C are cost-effective for some patients, according to a study, but high costs may become a barrier to use.
https://immattersacp.org/weekly/archives/2015/03/31/5.htm
31 Mar 2015
New meningitis vaccine, hepatitis C drug approved
Recalls and approvals.
https://immattersacp.org/archives/2015/01/fda.htm
1 Jan 2015
ID, liver societies update guidance for HCV testing, management
Major changes to guidance on hepatitis C virus (HCV) include an emphasis on universal screening, new recommendations for managing incomplete treatment adherence, and expansion of treatment eligibility, among others.
https://immattersacp.org/weekly/archives/2023/06/06/1.htm
6 Jun 2023